NAPLEX Practice Exam 2026 – All-in-One Guide to Mastering the North American Pharmacist Licensure Examination!

The other options are incorrect because they are either too high or too low of a dosage to be effective in reducing the risk of major CVD events in CAD/PAD with Rivaroxaban. Option A, 20 mg QD, is too high and could lead to adverse side effects, while option B, 15 mg BID, may also be too high and BID dosing can be challenging for patients to adhere to. Option C, 10 mg QD, may not be sufficient to effectively reduce the risk. Therefore, option D, 2.5 mg BID, is the recommended dosage for this purpose.